A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan 11, 2021. [Photo/Agencies] SHANGHAI - American biotech company Moderna on Monday commenced construction ...

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

(Reuters) -Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune ...

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable ...

The Moderna logo is seen at the Moderna campus in Norwood, Massachusetts on on December 2, 2020, where the biotechnology company is mass producing its Covid-19 vaccine. Moderna announced Wednesday ...

US President Donald Trump's administration on Wednesday canceled a $590 million contract with Moderna to develop an avian flu vaccine, the US biotech company said.

Visit a quote page and your recently viewed tickers will be displayed here. Corinne Le Goff currently works at Pacific Council on International Policy, as Director from 2019, Leem, as Director, ...

Moderna MRNA-1.37%decrease ... it expects demand to increase during cold and flu season later this year. The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, posted a net ...

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and ... Vaccine stocks such as Moderna (MRNA) fell more than 10% in early trading Monday.

A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan 11, 2021. [Photo/Agencies] SHANGHAI - US biotechnology company Moderna inked a strategic cooperation ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against ...